Bioherent
About:
Bioherent is a provider of diagnostic test for drug allergies.
Website: https://bioherent.com/
Top Investors: Centre for the Development of Industrial Technology (CDTI), Bullnet Capital
Description:
Bioherent develops in vitro diagnostic systems for the detection of allergies to beta-lactam antibiotics. Bioherent is based on integrated photonic sensors, and the company provides medical diagnostic tests for the detection of drug allergies. It develops sensitive, low-cost, in-vitro medical diagnostic technology. They develop in vitro diagnostic systems for the detection of allergies to beta-lactam antibiotics.
1.37M EUR
Alhaurín De La Torre, Andalucia, Spain
2021-01-01
11-50
2022-02-21
Private
© 2025 bioDAO.ai